March 29, 2019
Northern Biologics Reports Initial Phase I Data for MSC-1 at AACR
TORONTO–(BUSINESS WIRE)–Northern Biologics Inc., a company focused on developing first-in-class immuno-oncology products, today announced the presentation of initial results from…